results and impact of tailorx: trial assigning individualized options for treatment (rx)
Published 8 years ago • 355 plays • Length 4:24Download video MP4
Download video MP3
Similar videos
-
2:23
current status and future prospective of trial assigning individualized options for treatment (rx)
-
2:54
groundbreaking tailorx trial results on women with breast cancer
-
4:33
tailorx: genomic test helps identify low-risk women who do not need chemotherapy
-
1:10
dr. steven shak on the results of the tailorx trial for breast cancer
-
5:03
what is the tailorx clinical trial?
-
5:34
tailorx: phase 3 trial validating a 21-gene expression assay in breast cancer
-
4:48
oncotype dx testing and the tailorx trial
-
4:13
genomic predictors for treatment selection in er breast cancer: tailorx, mindact, and rxponder
-
12:19
less chemotherapy for breast cancer: the tailorx results
-
5:59
tailorx study explained by a medical oncologist
-
33:23
oncotype dx breast recurrence score assay after tailorx and rxponder: what’s next?
-
15:23
tailorx
-
5:47
the impact of the oncotype dx® recurrence score® on treatment decisions in breast cancer patients
-
1:27
the value of an intermediate recurrence score® result in the oncotype dx® breast cancer assay
-
17:07
the rxponder trial and its impact on best clinical practice
-
7:41
introduction to breast cancer: tailorx recap
-
5:59
impact of the tailorx trial on bc management
-
5:19
tailorx: an update incl 12-year event rates in woman with er lymph node-negative breast cancer
-
3:04
tailorx clinical trials